Fintel reports that on December 19, 2024, Wells Fargo upgraded their outlook for C4 Therapeutics (NasdaqGS:CCCC) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 287.97% Upside As of ...

It doesn’t take a thermometer to realize that WWE is red-hot. Historically speaking, the promotion has never made more money. After strategically shifting to a TV-PG product, brand sponsorships ...